Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Equipment
Research output
Press/Media
Search by expertise, name or affiliation
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection
Sang Hoon Ahn
, Won Kim
,
Young Kul Jung
, Jin Mo Yang
, Jae Young Jang
, Yong Oh Kweon
, Yong Kyun Cho
, Yoon Jun Kim
, Gun Young Hong
, Dong Joon Kim
, Soon-Ho Um
, Joo Hyun Sohn
, Jin Woo Lee
, Sung Jae Park
, Byung Seok Lee
, Ju Hyun Kim
, Hong Soo Kim
, Seung Kew Yoon
, Moon Young Kim
, Hyung Joon Yim
Kwan Sik Lee, Young Suk Lim, Wan Sik Lee, Neung Hwa Park, So Young Jin, Kyun Hwan Kim, Won Choi, Kwang Hyub Han
*
Show 8 more
Show less
*
Corresponding author for this work
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adefovir Dipivoxil
100%
Antiviral Efficacy
18%
Bone Mineral Density
27%
Chronic Hepatitis B Virus Infection
100%
Efficacy Endpoint
18%
Estimated Glomerular Filtration Rate
18%
Hepatitis B Virus
9%
Hepatitis B Virus DNA
9%
Hip Bone
9%
No Significant Difference
9%
Non-inferiority
9%
Non-inferiority Trial
9%
Phase II Study
9%
Renal Outcome
18%
Response to Therapy
9%
Safety Analysis
9%
Safety Profile
9%
South Korea
9%
Spine Bone
9%
Tenofovir Disoproxil Fumarate
100%
Virological Response
27%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
18%
Besifovir
100%
Chronic Hepatitis B
100%
Hepatitis B Virus
18%
Maleic Acid
100%
Noninferiority Trial
9%
Tenofovir Disoproxil
100%
Virus DNA
9%